SARS2 simplified scores to estimate risk of hospitalization and death among patients with COVID-19.


Journal

medRxiv : the preprint server for health sciences
Titre abrégé: medRxiv
Pays: United States
ID NLM: 101767986

Informations de publication

Date de publication:
13 Sep 2020
Historique:
entrez: 16 9 2020
pubmed: 17 9 2020
medline: 17 9 2020
Statut: epublish

Résumé

Although models have been developed for predicting severity of COVID-19 based on the medical history of patients, simplified risk prediction models with good accuracy could be more practical. In this study, we examined utility of simpler models for estimating risk of hospitalization of patients with COVID-19 and mortality of these patients based on demographic characteristics (sex, age, race, median household income based on zip code) and smoking status of 12,347 patients who tested positive at Mass General Brigham centers. The corresponding electronic health records were queried from 02/26/2020 to 07/14/2020 to construct derivation and validation cohorts. The derivation cohort was used to fit a generalized linear model for estimating risk of hospitalization within 30 days of COVID-19 diagnosis and mortality within approximately 3 months for the hospitalized patients. On the validation cohort, the model resulted in c-statistics of 0.77 [95% CI: 0.73-0.80] for hospitalization outcome, and 0.72 [95% CI: 0.69-0.74] for mortality among hospitalized patients. Higher risk was associated with older age, male sex, black ethnicity, lower socioeconomic status, and current/past smoking status. The model can be applied to predict risk of hospitalization and mortality, and could aid decision making when detailed medical history of patients is not easily available.

Identifiants

pubmed: 32935112
doi: 10.1101/2020.09.11.20190520
pmc: PMC7491527
pii:
doi:

Types de publication

Preprint

Langues

eng

Subventions

Organisme : NHLBI NIH HHS
ID : K01 HL135342
Pays : United States
Organisme : NHLBI NIH HHS
ID : K24 HL136852
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL117861
Pays : United States
Organisme : NHLBI NIH HHS
ID : T32 HL007575
Pays : United States

Commentaires et corrections

Type : UpdateIn

Références

N Engl J Med. 2020 Jun 25;382(26):2534-2543
pubmed: 32459916
Circulation. 2020 Jul 7;142(1):4-6
pubmed: 32320270
J Infect. 2020 Aug;81(2):e93-e95
pubmed: 32417309
J Am Med Inform Assoc. 2018 Oct 1;25(10):1419-1428
pubmed: 29893864
Intern Emerg Med. 2020 Aug;15(5):853-856
pubmed: 32430652
Nature. 2020 Aug;584(7821):430-436
pubmed: 32640463
Nat Med. 2020 Aug 24;:
pubmed: 32839624
Health Aff (Millwood). 2020 Sep;39(9):1624-1632
pubmed: 32663045
J Heart Lung Transplant. 2020 May;39(5):405-407
pubmed: 32362390
Curr Probl Cardiol. 2020 Aug;45(8):100617
pubmed: 32402515
JAMA. 2020 Apr 7;323(13):1239-1242
pubmed: 32091533
Clin Infect Dis. 2020 Jul 28;71(15):896-897
pubmed: 32271368
N Engl J Med. 2020 Jun 18;382(25):2441-2448
pubmed: 32356628
JAMA Intern Med. 2020 Jul 15;:
pubmed: 32667669
JAMA. 2020 Apr 28;323(16):1574-1581
pubmed: 32250385
JAMA Pediatr. 2020 Jun 3;:e202430
pubmed: 32492092
N Engl J Med. 2020 Jun 18;382(25):e102
pubmed: 32356626
JAMA Intern Med. 2020 Jul 15;:
pubmed: 32667668
Obesity (Silver Spring). 2020 Jul;28(7):1200-1204
pubmed: 32352637
N Engl J Med. 2020 May 21;382(21):2005-2011
pubmed: 32220208
EClinicalMedicine. 2020 Jun 03;23:100404
pubmed: 32632416
N Engl J Med. 2020 May 15;:
pubmed: 32412710
NPJ Digit Med. 2019;2:
pubmed: 31119199
Am J Infect Control. 2020 Jul 10;:
pubmed: 32659414
JAMA. 2015 Jan 6;313(1):29-30
pubmed: 25562260
Eur J Intern Med. 2020 May;75:107-108
pubmed: 32192856
Med Care. 2014 Feb;52(2):144-8
pubmed: 24309669
Am J Cardiovasc Drugs. 2020 Aug;20(4):311-324
pubmed: 32578167

Auteurs

Hesam Dashti (H)

Center for Lipid Metabolomics, Division of Preventive Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA.

Elise C Roche (EC)

Center for Lipid Metabolomics, Division of Preventive Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA.

David William Bates (DW)

Center for Lipid Metabolomics, Division of Preventive Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA.

Samia Mora (S)

Center for Lipid Metabolomics, Division of Preventive Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA.

Olga Demler (O)

Center for Lipid Metabolomics, Division of Preventive Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA.

Classifications MeSH